BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16885714)

  • 1. Pharmacokinetics and pharmacotherapy of thionamides in pregnancy.
    Clark SM; Saade GR; Snodgrass WR; Hankins GD
    Ther Drug Monit; 2006 Aug; 28(4):477-83. PubMed ID: 16885714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F; Amouzegar A
    Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.
    Atkins P; Cohen SB; Phillips BJ
    Drug Saf; 2000 Sep; 23(3):229-44. PubMed ID: 11005705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyrostatic treatment and its adverse effects].
    Dokupilová A; Payer J
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology and dosage of thyrostatic drugs].
    Passath A; Leb G; Warnkross H
    Acta Med Austriaca; 1987; 14(3-4):72-4. PubMed ID: 2447738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
    Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
    Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperthyroidism and pregnancy].
    Martínez Martín MA; Fernández Villoria E; Palacios S; Casquet MC; Crespo E
    Rev Clin Esp; 1981 Nov; 163(3):163-8. PubMed ID: 6173897
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the medical treatment of Graves' hyperthyroidism.
    Marinò M; Latrofa F; Menconi F; Chiovato L; Vitti P
    J Endocrinol Invest; 2014 Nov; 37(11):1041-8. PubMed ID: 25185644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing in pregnancy. Thyroid disease.
    Burr WA
    Clin Obstet Gynaecol; 1981 Aug; 8(2):341-51. PubMed ID: 6170485
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical management of hyperthyroidism.
    Trepanier LA
    Clin Tech Small Anim Pract; 2006 Feb; 21(1):22-8. PubMed ID: 16584027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole.
    Skellern GG; Knight BI; Otter M; Low CK; Alexander WD
    Br J Clin Pharmacol; 1980 Feb; 9(2):145-7. PubMed ID: 7356901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.